Financial release and supplemental presentation accessible onlineBOSTON, Nov. 5, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that financial results for its second quarter fiscal year 2027, which
VANCOUVER, BC, Oct. 19, 2026 /CNW/ -- Stock Preachers News Commentary - Big tech drove a sharp rebound into the close, with the Nasdaq Composite up 1.11% and the S&P 500 up 0.66% on the session, while the Dow Jones
BOSTON, Oct. 19, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced U.S. Food
BOSTON, Sept. 30, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that the Company intends to publish second quarter fiscal year 2027 financial results at 6:00 am ET on Thursday, November 5, 2026. The
Payment follows approximately $5 million received in January 2026, bringing total cash proceeds received to approximately $11 millionCompany remains eligible for up to approximately $10 million in additional proceeds
Current Director Dr. Martin Madaus Appointed Interim CEOCompany Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue GuidanceBURLINGTON, Mass., Aug. 24, 2026 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA)
Financial release and supplemental presentation accessible onlineBOSTON, Aug. 6, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that financial results for its first quarter fiscal year 2027, which
BOSTON, Aug. 3, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced
BOSTON, July 28, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced today that
BOSTON, July 8, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that the Company intends to publish first quarter fiscal year 2027 financial results at 6:00 am ET on Thursday, August 6, 2026. The
BOSTON, June 5, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced an update to
BOSTON, June 2, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Goldman Sachs 47th Annual Global Healthcare
Financial release and supplemental presentation accessible onlineBOSTON, May 7, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that financial results for its fourth quarter fiscal year 2026, which
BOSTON, May 5, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Bank of America 2026 Healthcare Conference
BOSTON, April 24, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced the
